Bremer Trust National Association raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 18.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,830 shares of the company’s stock after purchasing an additional 1,371 shares during the quarter. Bremer Trust National Association’s holdings in Colgate-Palmolive were worth $655,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Blue Chip Partners Inc. increased its stake in shares of Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after acquiring an additional 8 shares during the last quarter. M Holdings Securities Inc. increased its stake in shares of Colgate-Palmolive by 0.4% in the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after acquiring an additional 21 shares during the last quarter. Savant Capital LLC increased its stake in shares of Colgate-Palmolive by 0.3% in the first quarter. Savant Capital LLC now owns 10,526 shares of the company’s stock worth $770,000 after acquiring an additional 30 shares during the last quarter. Smith Moore & CO. increased its stake in shares of Colgate-Palmolive by 0.3% in the first quarter. Smith Moore & CO. now owns 10,373 shares of the company’s stock worth $759,000 after acquiring an additional 32 shares during the last quarter. Finally, Front Street Capital Management Inc. increased its stake in shares of Colgate-Palmolive by 0.4% in the first quarter. Front Street Capital Management Inc. now owns 8,586 shares of the company’s stock worth $628,000 after acquiring an additional 32 shares during the last quarter. 73.16% of the stock is currently owned by institutional investors.

Shares of Colgate-Palmolive Company (CL) traded up 0.19% during midday trading on Friday, reaching $72.28. 4,662,365 shares of the company were exchanged. The company has a market capitalization of $63.67 billion, a P/E ratio of 26.86 and a beta of 0.80. The stock has a 50-day moving average price of $71.57 and a 200 day moving average price of $73.28. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The firm had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same period in the previous year, the business earned $0.70 EPS. The company’s revenue was down .5% compared to the same quarter last year. Equities research analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.

CL has been the topic of a number of research reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a research note on Tuesday, July 4th. Bank of America Corporation upped their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, May 31st. Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research note on Thursday, August 24th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research note on Thursday, May 25th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and issued a $75.00 price target on shares of Colgate-Palmolive in a research note on Monday, July 24th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $75.83.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/09/16/colgate-palmolive-company-cl-holdings-increased-by-bremer-trust-national-association.html.

In other news, CFO Dennis J. Hickey sold 73,872 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $71.80, for a total value of $5,304,009.60. Following the completion of the transaction, the chief financial officer now owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $72.41, for a total transaction of $277,547.53. Following the completion of the transaction, the insider now directly owns 53,022 shares of the company’s stock, valued at approximately $3,839,323.02. The disclosure for this sale can be found here. Insiders sold a total of 217,969 shares of company stock worth $15,693,933 over the last quarter. Company insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.